Help for you
and your family
Research for
the cure
Surviving
Lymphoma
Who we are You can help
lymphoma specialist Philippe Armand, M.D., Ph.D.

Philippe Armand, M.D., Ph.D.
___________

Director, Clinical Research, Lymphoma Program Associate Professor of Medicine, Harvard Medical School

Dana-Farber Cancer Institute


“I am honored and delighted to be the recipient of a Young Scientist Award from the Lymphoma Foundation of America. This award supports my work and fortifies my determination to improve the outcome of patients with lymphoma.

"My clinical and research interests revolve primarily around the use of stem cell transplantation for lymphoma. Part of my work involves creating and using databases of clinical information to better understand determinants of outcome and to generate hypotheses that can then be tested in clinical trials. I am specifically interested in clinical trials testing immunomodulatory agents after autologous and allogeneic stem cell transplantation. I am also interested in integrating new anti-lymphoma agents in the transplantation procedure to maximize its safety and efficacy."


©2024 Lymphoma Foundation of America. LymphomaHelp® All rights reserved.
lymphoma foundation of America
lymphoma specialist Philippe Armand, M.D., Ph.D.

Philippe Armand, M.D., Ph.D.
___________

Director, Clinical Research, Lymphoma Program Associate Professor of Medicine, Harvard Medical School

Dana-Farber Cancer Institute


“I am honored and delighted to be the recipient of a Young Scientist Award from the Lymphoma Foundation of America. This award supports my work and fortifies my determination to improve the outcome of patients with lymphoma.

"My clinical and research interests revolve primarily around the use of stem cell transplantation for lymphoma. Part of my work involves creating and using databases of clinical information to better understand determinants of outcome and to generate hypotheses that can then be tested in clinical trials. I am specifically interested in clinical trials testing immunomodulatory agents after autologous and allogeneic stem cell transplantation. I am also interested in integrating new anti-lymphoma agents in the transplantation procedure to maximize its safety and efficacy."

©2024 Lymphoma Foundation of America. LymphomaHelp® All rights reserved.
help and support for lymphoma patients and familyHelp for you and
your family
Research for
the cure
Surviving Lymphoma Who we
are
You can help

Philippe Armand, M.D., Ph.D.

lymphoma specialist Philippe Armand, M.D., Ph.D.

Director, Clinical Research, Lymphoma Program Associate Professor of Medicine, Harvard Medical School

Dana-Farber Cancer Institute


“I am honored and delighted to be the recipient of a Young Scientist Award from the Lymphoma Foundation of America. This award supports my work and fortifies my determination to improve the outcome of patients with lymphoma.

"My clinical and research interests revolve primarily around the use of stem cell transplantation for lymphoma. Part of my work involves creating and using databases of clinical information to better understand determinants of outcome and to generate hypotheses that can then be tested in clinical trials. I am specifically interested in clinical trials testing immunomodulatory agents after autologous and allogeneic stem cell transplantation. I am also interested in integrating new anti-lymphoma agents in the transplantation procedure to maximize its safety and efficacy."